Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Atropine effects during propofol anesthesia with sufentanil versus remifentanil in off-pump CABG
2012-002533-10Phase 4Active
- Sponsor
- University Medical Center Groningen
- Start
- Jul 2012
- Modality
- Classical Binding Small Molecules → Small Molecules, Small Molecules, Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label trial of atropine, propofol, sufentanil and remifentanil (2 arms), sponsored by University Medical Center Groningen. Primary endpoint: Change in cardiac output around atropine administration. Started Jul 2012; status: active.
02
Drugs
atropinepropofolsufentanilremifentanil
Beyond the preview
Go deeper on 2012-002533-10.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2012-002533-10.